COO & CFO
Victor Dillard is driven by the vision of transforming biotechnology through software and unlocking the full potential of genomics and personalized treatment.
Since founding Desktop Genetics (www.deskgen.com) in 2012, Victor has led the company’s business development and CRISPR genome-editing initiatives, placing the fast-growing company at the forefront of CRISPR therapeutics research. As COO & CFO, he is also responsible for raising c. $3M business financing to date, scaling the operations to support a 18-person team, and leading the execution of c. $1M of R&D projects.
Victor holds an MEng in Chemical Engineering from Imperial College London and an MPhil in Bioscience Enterprise from the University of Cambridge.
Venture Capital Investor
Ashish is a venture capital investor at Mercia Technologies, where he focuses on investing in early-stage UK life sciences, healthcare and biotech firms.
Prior to this he was the Clinical Technology Director at Babylon Health where he helped to build a multi-award winning medical technology platform which secured Europe’s largest ever Series A investment in digital health.
Ali is an engineer and a healthcare entrepreneur. He founded babylon in 2013 with the single aim of putting an accessible and affordable health service in the hand off of every person on earth. babylon combines the ever growing computing power of machines with the best medical expertise of humans to create a comprehensive, immediate, and personalised health service, and make it universally available (“set to revolutionise the healthcare system” Daily Telegraph). Prior to Babylon, Ali founded Circle and built it within a few years to become Europe’s largest partnership of clinicians, with some £200m of revenue, near 3,000 employees and a successful IPO.
Earlier, Ali was the recipient of the Royal Award for the Young Entrepreneur of the year for founding his first business, V&G, and the Healthcare Entrepreneurial Achievement Award for establishing Circle. Ali was named by The Times among the 100 global people to watch, and by HSJ among the 50 most influential people in healthcare. Ali is the UK Cabinet Office Ambassador for Mutuals and has a PhD in Engineering Physics.
Head of Artificial Intelligence
As a senior data scientist for Babylon Steven built a team of data scientists driving the development of statistical and machine learning models that advance our mission of providing health care to as many people as possible. As a part of that role he helped to define system architecture and roadmaps, built expertise in the team with specialized hires, and was instrumental in developing the tools and engines that power Bbabylon’s AI platform.
HealthTech Women UK
Maxine is currently undertaking a PhD at UCL in neuroinformatics, at the intersection of data science and dementia. She has also completed an MSc in Health Policy and Economics at the LSE and LSHTM. Maxine is the Managing Director of HealthTech Women in the UK, and has worked at the Royal Society, DFID, L’Oreal, Roche and as an MSc research assistant for NHS England on AHSNs. She continues to report and consult on medical innovation in the UK, central Europe and the Silicon Valley.
Medical Informatics Program
Universiteit van Amsterdam
Ronald obtained his doctorate degree in 2006. His research focuses on formal knowledge representation in medicine. Areas of interest are:
· Constructing formal terminological systems
· Auditing formal terminological systems
· Description logics, most notably OWL
· Standardization and definitions, e.g., HL7
· Applying terminological systems
He is currently teaching in the Medical Informatics Program at the Universiteit van Amsterdam.
Director of Biomedical Informatics and Design
John Overington is the Director of Bioinformatics at Stratified Medical. He is an experienced and creative drug discovery informatics scientist who is solely focussed on the development and application of workflows, data sources, and informatics methods to improve healthcare innovation through creative, collaborative and data-sharing approaches
Senior Research Fellow
John Fox, PhD. is professor of engineering science at Oxford University and an honorary professor in Statistics at Warwick University. His research interests range from computer science and cognitive science to AI and medical informatics. After training in psychology at Durham and Cambridge Universities, he was a postdoctoral fellow with AI founders Allen Newell and Herbert Simon, and with cognitive psychology pioneer Ulric Neisser. After returning to the UK he was an MRC research fellow at Sheffield University until he joined the Imperial Cancer Research Fund (now Cancer Research UK) where he established the Advanced Computation Lab at its Lincoln’s Inn Fields Laboratories in London. The Lab made contributions in decision science and cognitive systems theory as well as AI. A key practical result is the PROforma language, a versatile foundation for modelling decision and planning which is being used in many clinical applications. Fox has published widely (see Researchgate.org), including a book with Subrata Das Artificial Intelligence in Hazardous Applications (AAAI and MIT press, 2000) and he was founding editor of The Knowledge Engineering Review (Cambridge University Press). He has (unexpectedly) been a serial entrepreneur, founding several specialist companies, including InferMed Ltd (acquired by Elsevier in 2015) and most recently Deontics Ltd, a spinout from Oxford University, UCL and CRUK. His current passion is OpenClinical, a “crowdsourcing” project aimed at creating an open access, open source knowledge base for healthcare
Joseph founded Experto Crede in 1994. He led it to quickly become a global consultancy in the area of technology research, marketing & due diligence.
In 2006 he developed Growth Hub UK – Experto Crede’s corporate venturing arm. The hub focuses on the research, design, development and commercialisation of Data Science and AI driven technology. Its aim is to improve the lives of mobile phone users. By 2009 technology from Experto Crede was used daily by over 300 million smartphone users.
In a former life, Nathan spent a few years in academia, researching ways to stop cancer from spreading around the body. He joined Playfair Capital in 2013 to seek out, invest into and help grow technology companies. He is particularly interested in businesses where data and engineering are core competencies, as well as those which craft compelling user experiences that quickly become entrenched habits. He serves on the Board of Directors of Dojo and is a Board Observer at Festicket, Gluru and Trouva.
Deep Knowledge Ventures
Dmitry Kaminskiy is an investor and leader in the fields of biotechnology, financial technology, and artificial intelligence. He is known for his development of big data analytic systems with machine learning aspects. Targeting breakthroughs in Biotechnologies through the use of Big Data analytics, Dmitry has a wide network spanning the scientific and business communities across the globe.
Dmitry currently serves as the senior partner of Deep Knowledge Ventures, a Hong Kong investment fund which focuses on biotechnology, artificial intelligence, personalized medicine, big data analytical systems, and innovative financial technology. Deep Knowledge Ventures is not a traditional venture fund, as the fund uses artificial intelligence to carefully calculate which companies will have a truly disruptive impact.
Dr Antonio Criminisi
Antonio Criminisi received a Degree in Electronics Engineering at the Universita’ degli Studi di Palermo. He joined the Department of Engineering Science at the University of Oxford as a Research Assistant and there he obtained his Doctor of Philosophy Degree in Computer Vision.
Antonio Criminisi is principle researcher at Microsoft Research Cambridge. He works on the automatic analysis of medical images to increase the productivity of doctors and improve patient outcome by applying state of the art machine learning techniques.
Dr Goran Nenadic
The Farr Institute’s Health eResearch Centre
Dr Goran Nenadic is a Reader in the School of Computer Science, University of Manchester, and is a group leader in the Manchester Institute of Biotechnology (MIB) and The Farr Institute’s Health eResearch Centre (HeRC). He also leads the UK network in healthcare text analytics. His research interests are focused on text mining and semi-automated curation of knowledge from unstructured textual data. Goran has been working in the area of text mining and natural language processing since 1993. Current research projects focus on large-scale extraction and curation of biomedical information and clinical/epidemiological findings, by combining rule-based and data-driven approaches. He is also interested in processing clinical narratives and healthcare social media.
Dr Bissan Al-Lazikani
Computational Biology & Chemogenomics
Institute of Cancer Research
Dr Bissan Al-Lazikani’s research focuses on developing and applying multidisciplinary computational techniques for drug discovery and clinical application. D Passionate about the application of Big Data and machine learning to fight cancer, Dr Al-Lazikani is now leading the Knowledge Hub Big Data initiative to capture and analyse big clinical and preclinical data to enable data-driven adaptive therapy. She was appointed Head of Data Science at the ICR to help deliver the joint ICR and Royal Marsden NHS Foundation Trust research strategy.
Data Insights Cambridge
Sobia completed her PhD in Epigenetics at the University of Cambridge, undertaking her research into genomic imprinting at The Babraham Institute. In 2011 Sobia founded Data Insights Cambridge, a networking community for data scientists. Dr Sobia Hamid recently wrote a paper for The Wilberforce Society advising policy makers on the opportunities and risks of artificial intelligence in medicine and healthcare. Sobia has been working in the area of personalised medicine and machine learning undertaking scientific and commercial due diligence and marketing for venture capital, biotech and pharma companies.
Since 1995, Matteo Berlucchi has founded and run several start-ups across the major verticals of the digital spectrum. He is an expert in small-to-large scale digital businesses and digital health. He is CEO of Your.MD, building a breakthrough end-to-end Artificial Intelligence (AI) platform for pre-primary care. His aim is to build the biggest healthcare company in the world to help every human-being have basic healthcare without owning any hospitals or doctors.
Emma Dickinson is a corporate technology lawyer at Taylor Vinters. She has a particular interest in the intersection of health and tech and has recently started working with start-ups in this space. After completing a degree in Neuroscience, she trained and qualified at Norton Rose Fulbright.
Director for National Disease Registration
Public Health England
Dr Jem Rashbass, Director for National Disease Registration, Public Health England
Jem Rashbass studied medicine at University College London was a graduate student of Professor Sir John Gurdon in Cambridge, then trained in diagnostic pathology, becoming a clinical academic dividing his time between clinical work and the creation of Clinical and Biomedical Computing Unit at Cambridge University.
In 2003 he became head of the Eastern Cancer Registry and Information Centre, a post he held in conjunction with the leadership of the East of England Cancer Screening Quality Assurance Service. In April 2013 was appointed National Director for Disease Registration in PHE responsible for the 300 staff in National Disease Registration; in January 2016 he also combined the oversight of the cancer analysis functions to create the new National Cancer Registration and Analysis Service for England.
Sam Smith works for medConfidential, an independent non-partisan organisation campaigning for confidentiality and consent in health and social care, which seeks to ensure that every flow of data into, across and out of the UK’s Health Service is an appropriate balance of consensual, safe and transparent. Sam previously worked for Privacy International, where he spoke in parliament about drones, and in other places about the collection of communications data. Prior to working for Privacy International, he spent a decade designing and building research infrastructures for quantitative and qualitative social scientists.
Director of Digital & Multi Channel Development
Deborah is the Director of Digital and Multi-Channel at NHS England. Her career spans 25 years in the NHS across primary, secondary, mental health and learning disability services. She has worked in operational delivery, innovation, service redesign and for the last 12 years specialising in digital and technology. She has won awards for innovation and excellence in public services.
Deborah is the Senior Responsible Officer for NHS Choices/ NHS.Uk, Widening Digital Participation for citizens as well as digital programmes supporting the development of urgent care. She has a specific interest in exploring the use of AI, machine learning and cutting edge technology to drive the best possible delivery of care. As well as her national role Deborah is engaged with a number of local NHS organisations.
Clinical Director of Innovation
Alder Hey Children's Hospital
Iain Hennessey is a consultant paediatric surgeon and clinical director of innovation at Alder Hey Children’s Hospital in Liverpool. He graduated with honours from the University of Edinburgh and went on to train in paediatric surgery and urology at the Royal Manchester Children’s, Adelaide and Alder Hey Children’s Hospitals.
As director of innovation, he has built the Alder Hey innovation service into an internationally recognised entity by brokering partnerships with large corporations including BT, Sony, Panasonic and IBM through to local SME’s. In 2014 this was recognised by winning the improving healthcare with technology category at the Health Service Journal awards.
Salford NHS Foundation Trust
Rachel has extensive experience in the NHS and Private Sector, is a curator of TEDx events and has a passion for innovation and looking at how we can do things differently. She believes that innovation both technical and non-technical can provide the answers that the NHS needs in delivering new models of care. Rachel is CIO of Bolton NHS Foundation Trust and Salford Royal NHS Foundation Trust She also sits on a number of international, national and local advisory boards and bodies including the NHS Open Source Board, KLAS Research advisory board and ITIL qualification panel.